Devin Steenkamp
YOU?
Author Swipe
Metabolic medications modify prostate cancer progression through exosome reprogramming Open
Among prostate cancer patients, co-morbid Type 2 Diabetes (T2D) is associated with faster progression to biochemical recurrence and increased risk of mortality. Previous work from our lab provides evidence that exosomes purified from media…
View article: Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes
Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes Open
OBJECTIVE To assess the effect of automated insulin delivery (AID) on glycemic and insulin outcomes in adults with insulin-treated type 2 diabetes using a glucagon-like peptide-1 receptor agonist (GLP-1 RA). RESEARCH DESIGN AND METHODS In …
View article: Simplified Meal Bolus Strategies with Control-IQ+ Automated Insulin Delivery Are Safe and Effective in Adults with Type 2 Diabetes
Simplified Meal Bolus Strategies with Control-IQ+ Automated Insulin Delivery Are Safe and Effective in Adults with Type 2 Diabetes Open
Objective: To characterize simplified meal bolus strategies in adults with insulin-treated type 2 diabetes using automated insulin delivery (AID). Research Design and Methods: In the 2IQP study, a 13-week randomized, controlled trial compa…
Associations of diet composition and quality with continuous glucose monitor-derived glycemic metrics in a community-based cohort Open
Our findings demonstrate that carbohydrate intake and quality, in addition to overall diet quality, are associated with dynamic fluctuations in glucose concentrations. Future prospective analysis should examine whether glycemic variability…
View article: Workshop on Noninvasive Glucose Monitoring 2024
Workshop on Noninvasive Glucose Monitoring 2024 Open
This first workshop on noninvasive glucose monitoring (NIGM) was held at the Massachusetts Institute of Technology (MIT) on October 30, 2024. Six invited speakers, representing industry, academia, and clinics, gave presentations that cover…
View article: Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes
Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes Open
Background: Clinical interpretation of continuous glucose monitoring (CGM) data for people without diabetes has not been well established. This study aimed to investigate concordance among CGM experts in recommending clinical follow-up for…
Continuous Glucose Monitoring–Enhanced eConsult Improves Clinical Outcomes in Adults Living With Diabetes in a Safety Net Primary Care Setting Open
Background: There is a shortage of endocrinologists providing diabetes care. Electronic consultation (eConsult) improves access to subspecialty care, but the evaluation of CGM‐enhanced eConsults in routine clinical practice has not been re…
View article: A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 Diabetes.
A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 Diabetes. Open
OBJECTIVE: To evaluate a regimen of inhaled Technosphere insulin (TI) plus insulin degludec in adults with type 1 diabetes, who prestudy were predominately using either an automated insulin delivery (AID) system or multiple daily insulin i…
View article: A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults with Type 1 Diabetes
A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults with Type 1 Diabetes Open
Objective: To evaluate a regimen of inhaled technosphere insulin (TI) plus insulin degludec in adults with type 1 diabetes, who prestudy were predominately using either an automated insulin delivery system (AID) or multiple daily insulin i…
View article: A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults with Type 1 Diabetes
A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults with Type 1 Diabetes Open
Objective: To evaluate a regimen of inhaled technosphere insulin (TI) plus insulin degludec in adults with type 1 diabetes, who prestudy were predominately using either an automated insulin delivery system (AID) or multiple daily insulin i…
View article: A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 Diabetes
A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 Diabetes Open
OBJECTIVE To evaluate a regimen of inhaled Technosphere insulin (TI) plus insulin degludec in adults with type 1 diabetes, who prestudy were predominately using either an automated insulin delivery (AID) system or multiple daily insulin in…
View article: <b>Diabetes Centers’ Participation in the T1D Exchange Quality Improvement Collaborative Advances Health Equity and Clinical Outcomes</b>
<b>Diabetes Centers’ Participation in the T1D Exchange Quality Improvement Collaborative Advances Health Equity and Clinical Outcomes</b> Open
As the learning health network known as the T1D Exchange Quality Improvement Collaborative (T1DX-QI) has expanded on a significant scale to provide care for more than 120,000 people since its inception in 2016, assessing the quality improv…
View article: <b>Diabetes Centers’ Participation in the T1D Exchange Quality Improvement Collaborative Advances Health Equity and Clinical Outcomes</b>
<b>Diabetes Centers’ Participation in the T1D Exchange Quality Improvement Collaborative Advances Health Equity and Clinical Outcomes</b> Open
As the learning health network known as the T1D Exchange Quality Improvement Collaborative (T1DX-QI) has expanded on a significant scale to provide care for more than 120,000 people since its inception in 2016, assessing the quality improv…
Defining Continuous Glucose Monitor Time in Range in a Large, Community-Based Cohort Without Diabetes Open
Context Continuous glucose monitor (CGM) companies are beginning to market these sensors to populations without diabetes, but the range of CGM values clinicians should expect to see for this population is unclear because there have been no…
View article: A Randomized Comparison of Post-prandial Glucose Excursion Using Inhaled Insulin Versus Rapid-acting Analogue Insulin in Adults with Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery
A Randomized Comparison of Post-prandial Glucose Excursion Using Inhaled Insulin Versus Rapid-acting Analogue Insulin in Adults with Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery Open
Objective: To compare post-prandial glucose excursions following a bolus with inhaled technosphere insulin (TI) or subcutaneous rapid-acting analogue (RAA) insulin. Research Design and Methods: A meal challenge was completed by 122 adults …
View article: A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery
A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery Open
OBJECTIVE To compare postprandial glucose excursions following a bolus with inhaled technosphere insulin (TI) or subcutaneous rapid-acting analog (RAA) insulin. RESEARCH DESIGN AND METHODS A meal challenge was completed by 122 adults with …
View article: A Randomized Comparison of Post-prandial Glucose Excursion Using Inhaled Insulin Versus Rapid-acting Analogue Insulin in Adults with Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery
A Randomized Comparison of Post-prandial Glucose Excursion Using Inhaled Insulin Versus Rapid-acting Analogue Insulin in Adults with Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery Open
Objective: To compare post-prandial glucose excursions following a bolus with inhaled technosphere insulin (TI) or subcutaneous rapid-acting analogue (RAA) insulin. Research Design and Methods: A meal challenge was completed by 122 adults …
View article: Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease
Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease Open
The Kidney Precision Medicine Project (KPMP) aims to create a kidney tissue atlas, define disease subgroups, and identify critical cells, pathways, and targets for novel therapies through molecular investigation of human kidney biopsies ob…
Proof-of-concept Application of Continuous Glucose Monitoring Data Analytics to Identify Diabetes Glucotypes Open
Background In this proof-of-concept study, we evaluated if monogenic diabetes resulting from mutations of the HNF-1α gene (HNF1A-MODY) has a distinctive continuous glucose monitoring (CGM) glucotype, in comparison to type 1 diabetes (T1D).…
Making sense of glucose sensors in end-stage kidney disease: A review Open
Diabetes mellitus remains the leading cause of end-stage kidney disease worldwide. Inadequate glucose monitoring has been identified as one of the gaps in care for hemodialysis patients with diabetes, and lack of reliable methods to assess…
Baseline Quality Improvement Capacity of 33 Endocrinology Centers Participating in the T1D Exchange Quality Improvement Collaborative Open
This article describes the evolution of the Type 1 Diabetes Exchange Quality Improvement Collaborative (T1DX-QI) provide insights into the development and growth of a successful type 1 diabetes quality improvement (QI) program. Since its i…
View article: Baseline Quality Improvement Capacity of 33 Endocrinology Centers Participating in the T1D Exchange Quality Improvement Collaborative
Baseline Quality Improvement Capacity of 33 Endocrinology Centers Participating in the T1D Exchange Quality Improvement Collaborative Open
This article describes the evolution of the Type 1 Diabetes Exchange Quality Improvement Collaborative (T1DX-QI) and provides insight into the development and growth of a successful type 1 diabetes quality improvement (QI) program. Since i…
Baseline Quality Improvement Capacity of 33 Endocrinology Centers Participating in the T1D Exchange Quality Improvement Collaborative Open
This article describes the evolution of the Type 1 Diabetes Exchange Quality Improvement Collaborative (T1DX-QI) provide insights into the development and growth of a successful type 1 diabetes quality improvement (QI) program. Since its i…
View article: Achieving Equity in Diabetes Research: Borrowing From the Field of Quality Improvement Using a Practical Framework and Improvement Tools
Achieving Equity in Diabetes Research: Borrowing From the Field of Quality Improvement Using a Practical Framework and Improvement Tools Open
There are limited tools to address equity in diabetes research and clinical trials. The T1D Exchange has established a 10-step equity framework to advance equity in diabetes research. Herein, the authors outline this approach and expand on…
An Opportunity for Improvement: Evaluation of Diabetes Technology Education Among Adult Endocrinology Training Programs Open
Background: Despite increases in continuous glucose monitor (CGM) and insulin pump use in adults with diabetes, there is room for expansion. Technology adoption may be influenced by the training environment and fellowship education. Howeve…